Great West Life Assurance CO Vaxart, Inc. Transaction History

Great West Life Assurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$2.09 - $4.5 $72,493 - $156,087	34,686 New	34,686 $75,000
Q2 2022 Aug 09, 2022	BUY	$2.7 - $5.28 $1,773 - $3,468	657 Added 9.35%	7,682 $26,000
Q1 2022 May 12, 2022	BUY	$4.29 - $6.64 $2,629 - $4,070	613 Added 9.56%	7,025 $37,000
Q4 2021 Feb 14, 2022	BUY	$5.77 - $7.96 $3,340 - $4,608	579 Added 9.93%	6,412 $40,000
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $20,415 - $46,547	5,833 New	5,833 $33,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.